Cottage cheese as late night snack can boost health | WeForNews | Latest News, Blogs Cottage cheese as late night snack can boost health – WeForNews | Latest News, Blogs
Connect with us

Health

Cottage cheese as late night snack can boost health

Published

on

cottage-cheese

New York, Oct 26: Guilty about your late night snacking habit that leads to weight gain? Switching to a protein-filled snack like cottage cheese can help you to have a positive effect on muscle quality, metabolism and overall health, say, researchers.

In the study, Michael Ormsbee, Associate Professor at Florida State University (FSU), gave active young women in their early 20s samples of cottage cheese 30 to 60 minutes before bedtime.

They found that consuming 30 grams of protein about 30 minutes before bed appears to have a positive effect on muscle quality, metabolism and overall health.

And for those who have sworn off eating at night, there is no gain in body fat, revealed the findings published in the British Journal of Nutrition.

“Until now we presumed that whole foods would act similarly to the data on supplemental protein but we had no real evidence,” Ormsbee said.

“This is important because it adds to the body of literature that indicates that whole foods work just as well as protein supplementation, and it gives people options for pre-sleep nutrition that go beyond powders and shaker bottles.”

The results serve as a foundation for future research on precise metabolic responses to whole food consumption.

“While protein supplements absolutely have their place, it is important to begin pooling data for foods and understanding the role they can play in these situations,” said former FSU graduate student Samantha Leyh, now a research dietician with the Air Force.

“Like the additive and synergistic effects of vitamins and minerals when consumed in whole food form such as fruits or veggies, perhaps whole food sources may follow suit,” Leyh said.

The study will help examine more pre-sleep food options and the optimal food choices that can aid individuals in recovery from exercise, repair and regeneration of muscle and overall health, the researchers noted.

IANS

Health

Modi interacts with 3 teams developing corona vaccines

The Prime Minister also asked the companies to come out with their suggestions and ideas regarding the regulatory processes and related matters.

Published

on

By

Narendra Modi

New Delhi, Nov 30: Prime Minister Narendra Modi on Monday held virtual meetings with three teams working on the development and manufacture of vaccines against Covid-19, and discussed the potential of various platforms for vaccine development.

The teams are from Gennova Biopharmaceuticals Ltd at Pune, and Biological E Ltd and Dr Reddy’s Laboratories Ltd at Hyderabad.

Their potential vaccines are in different stages of trials and detailed data and results are expected from early next year onwards, a Prime Minister’s Office (PMO) statement said on Monday.

“The potential of various platforms for vaccine development was also discussed,” the statement said.

The Prime Minister also asked the companies to come out with their suggestions and ideas regarding the regulatory processes and related matters.

He also suggested that they should make extra efforts to inform the general public in simple language about the vaccine and related matters such as its efficacy.

Matters relating to logistics, transport and cold chains in respect of delivery of the vaccines were also discussed.

The Prime Minister advised all departments concerned to engage with the manufacturers and seek to resolve matters so that the efforts by these companies bear fruit in order to serve the needs of the country and the entire world.

The Prime Minister praised the efforts made by scientists and researchers in these companies to come out with a vaccine solution to tackle the ongoing coronavirus pandemic, which so far has infected 94,31,692 people across the country, and led to deaths of 1,37,139 patients.

Continue Reading

Health

With 38k new Covid-19 cases, India’s tally tops 94.3 lakhs

The recovery rate stands at 93.81 per cent, and the fatality rate is 1.45 as per cent, the Ministry said.

Published

on

By

DELHI-CORONAVIRUS

New Delhi, Nov 30: With 38,772 new coronavirus cases and 443 deaths in the past 24 hours, India’s overall tally stood at 94,31,692 on Monday, as the fatality toll touched 1,37,139, the Ministry of Health and Family Welfare said.

Currently, there are 4,46,952 active cases, whereas 8,84,76,00 patients have been cured and discharged so far.

The recovery rate stands at 93.81 per cent, and the fatality rate is 1.45 as per cent, the Ministry said.

“India continues to have one of the lowest deaths per million population globally (presently 99). Focussed measures to ensure a low and manageable fatality rate have resulted in daily mortality figures of less than 500,” it added.

Maharashtra continued to be the worst-hit state with 1,820,059 cases till date. There are 92,062 active cases and 47,071 Covid-19 deaths.

According to the Ministry, over 70 per cent of the daily new cases are contributed by eight States and UT i.e. Maharashtra, Delhi, Kerala, West Bengal, Rajasthan, Uttar Pradesh, Haryana, and Chhattisgarh.

The overall number of global coronavirus cases has topped 62.6 million, while the deaths have surged to more than 1.45 million, according to the Johns Hopkins University.

In its latest update on Monday, the University’s Center for Systems Science and Engineering (CSSE) revealed that the current global caseload and death toll stood at 62,670,153 and 1,458,360, respectively.

The US is the worst-hit country with the world’s highest number of cases and deaths at 13,374,162 and 266,838, respectively, according to the CSSE.

India comes in second place in terms of cases.

Continue Reading

Health

Influenza infections may up pneumonia risk: Study

The presence of HtrA weakens the immune system and promotes bacterial growth in the influenza-infected airways. The lack of HtrA stops bacterial growth.

Published

on

By

H1N1 influenza

London, Nov 29: Researchers have now revealed that influenza infections can lead to an increased risk of bacterial pneumonia, which claims many lives around the world every year.

Using an animal model, the study, published in the journal PNAS found that different nutrients and antioxidants, such as vitamin C and other normally cell-protective substances leak from the blood, thereby creating an environment in the lungs that favours the growth of the bacteria.

The bacteria adapt to the inflammatory environment by increasing the production of the bacterial enzyme HtrA.

The presence of HtrA weakens the immune system and promotes bacterial growth in the influenza-infected airways. The lack of HtrA stops bacterial growth.

“The ability of pneumococcus to grow in the lower airways during an influenza infection seems to depend on the nutrient-rich environment with its higher levels of antioxidants that occurs during a viral infection, as well as on the bacteria’s ability to adapt to the environment and protect itself from being eradicated by the immune system,” said study author Birgitta Henriques Normark from Karolinska Institutet in Sweden.

The results provide valuable information on how bacteria integrate with their environment in the lungs and could be used to find new therapies for double infections between the influenza virus and pneumococcal bacteria.

“HtrA is an enzyme, a protease, which helps to weaken the immune system and allows pneumococcal bacteria to penetrate the protective cell layer on the inside of the airways,” said study author Vicky Sender.

“A possible strategy can therefore be the use of protease inhibitors to prevent pneumococcal growth in the lungs,” Sender added.

It is still not known if Covid-19 patients are also sensitive to such secondary bacterial infections, but the researchers think that similar mechanisms could potentially be found in severely ill Covid-19 patients.

“It’s likely that acute lung inflammation, regardless of cause, gives rise to leakage of nutrients and antioxidants, and to an environment that fosters bacterial growth,” Henriques Normark noted.

Continue Reading
Advertisement

Most Popular

Corona Virus (COVID-19) Live Data

COVID-19 affects different people in different ways. Most infected people will develop mild to moderate illness and recover without hospitalization.